|
NHLRC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.675800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.195000E-01 |
| Normal-vs-Stage2 |
7.382000E-01 |
| Normal-vs-Stage3 |
4.955700E-02 |
| Normal-vs-Stage4 |
8.202200E-03 |
| Stage1-vs-Stage2 |
5.161600E-02 |
| Stage1-vs-Stage3 |
3.585000E-01 |
| Stage1-vs-Stage4 |
3.328500E-02 |
| Stage2-vs-Stage3 |
1.187570E-02 |
| Stage2-vs-Stage4 |
3.042300E-03 |
| Stage3-vs-Stage4 |
2.032200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.848000E-02 |
| Normal-vs-AfricanAmerican |
4.486600E-01 |
| Normal-vs-Asian |
4.751800E-01 |
| Caucasian-vs-AfricanAmerican |
5.932000E-01 |
| Caucasian-vs-Asian |
1.221990E-01 |
| AfricanAmerican-vs-Asian |
8.142800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.717400E-01 |
| Normal-vs-Female |
3.664300E-02 |
| Male-vs-Female |
2.736000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.911800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.634840E-01 |
| Normal-vs-Age(61-80Yrs) |
6.848300E-02 |
| Normal-vs-Age(81-100Yrs) |
9.462800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.779000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.333200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.629800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.876600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.474000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.529200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.796800E-04 |
| Classical-VS-Follicular |
6.41789999999975E-05 |
| Classical-VS-Other |
9.586200E-01 |
| Classical-VS-Normal |
3.077600E-02 |
| Tall-VS-Follicular |
5.12179998413131E-09 |
| Tall-VS-Other |
3.779600E-01 |
| Tall-VS-Normal |
1.200330E-04 |
| Follicular-VS-Other |
2.209400E-01 |
| Follicular-VS-Normal |
4.106800E-01 |
| Other-VS-Normal |
4.226400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.498800E-01 |
| Normal-vs-N1 |
7.150600E-04 |
| N0-vs-N1 |
4.30559999999858E-05 |
|
|
